Clinical trials
Cardiomyopathy, Hypertrophic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 13 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 17 |
| Terminated | 13 |
| Active, not recruiting | 11 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 23 |
| Bristol-Myers Squibb | 15 |
| Cytokinetics | 5 |
| Mayo Clinic | 5 |
| The Cleveland Clinic | 4 |
| Brigham and Women's Hospital | 3 |
| MyoKardia, Inc. | 3 |
| Oregon Health and Science University | 3 |
| Duke University | 2 |
| Johns Hopkins University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 119 |
| Cardiomyopathies | 11 |
| Cardiomyopathy, Dilated | 11 |
| Heart Failure | 10 |
| Cardiomegaly | 7 |
| Heart Diseases | 7 |
| Hypertrophy, Left Ventricular | 7 |
| Cardiovascular Diseases | 6 |
| Arrhythmias, Cardiac | 5 |
| Aortic Valve Stenosis | 4 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.